Search

Four MSK clinicians were accepted into a career development program aimed at increasing diverse participation in clinical trials.

… Tuesday, November 16, 2021 On October 25, 2022, the Bristol Myers Squibb Foundation announced the second cohort of this program, now known as The Robert A. Winn Diversity in Clinical Trials Award Program. Two MSK clinicians, Drs. Fiyinfolu Balogun and Joshua Budhu , are in this second cohort and will

… Job Title Research Fellow - currently, Course Instructor, American Museum of Natural History Email [email protected]

An international phase 3 clinical trial has shown that adding a targeted therapy to a standard combination for stage 4 kidney cancer is more effective than giving the standard treatment alone, although the new combination has significant side effects.

… Wednesday, May 10, 2023 Michael Szczerbienski had always been blessed with good health, so the day he found blood in his urine , he was quite alarmed. His doctor sent him for a CT scan , which revealed a tumor on his left kidney. Michael, whose kidney cancer was already advanced, went to Memorial Sloan

As cancer survival continues to improve globally, attention is increasingly shifting toward survivorship outcomes that extend beyond disease control. Employment has emerged as a contextual factor associated with health-related quality of life, a potentially important, yet underexplored, factor in survivorship and well-being.

… As cancer survival continues to improve globally, attention is increasingly shifting toward survivorship outcomes that extend beyond disease control. Employment has emerged as a contextual factor associated with health-related quality of life, a potentially important, yet underexplored, factor in survivorship

… Job Title Associate Professor, Anesthesiology, Duke University, NC Degree PhD Start Year 1996 End Year 1999 Email [email protected]

… Job Title GSK Graduate Student

The Parker Institute sponsors several immunotherapeutic clinical trials. These are the PICI trials currently open for accrual at MSKCC.

… The Parker Institute sponsors several immunotherapeutic clinical trials. These are the PICI trials currently open for accrual at MSKCC.   PICI0044/ NCT04787991 A Multicenter, Open-label, ExploRatory Platform Trial to EValuate ImmunOtherapy Combinations With Chemotherapy for the Treatment of Patients

Allow this gentle mindfulness-based breath meditation to calm and support you in preparation for or during radiation therapy. Throughout this mediation there will be pauses and moments of silence to help you practice. (8 minutes)

… Allow this gentle mindfulness-based breath meditation to calm and support you in preparation for or during radiation therapy.  Throughout this mediation there will be pauses and moments of silence to help you practice. (8 minutes)

The Memorial Sloan Kettering – Hackensack Meridian Health Partnership has formed an Immunology Research Collaboration to support innovative investigations into the power of the immune system to fight cancer.

… Tuesday, June 9, 2020 As part of the Memorial Sloan Kettering – Hackensack Meridian Health Partnership, the two organizations have formed an Immunology Research Collaboration. Through this joint initiative, researchers can apply for funding to support innovative investigations to explore the power of

… Full Title exPDite-2: A Phase 3 Study to Assess the Efficacy and Safety of Midbrain Dopaminergic Neuronal Cell Therapy (Bemdaneprocel) for Participants With Parkinson’s Disease (Advarra IRB) Purpose Researchers want to see if bemdaneprocel improves symptoms in people with Parkinson’s disease (PD). PD